Results 241 to 250 of about 3,194,674 (312)

A real-world pharmacovigilance study of FDA adverse event reporting system events for bictegravir/emtricitabine/tenofovir alafenamide. [PDF]

Front Pharmacol
Liu Y, Zhang L, Li X, Zhao H.
europepmc   +1 more source

Non‐Additive Criteria Assessment in Sustainability Evaluation of High Entropy Alloys: A Toxicity‐Weighted Framework

Advanced Engineering Materials, EarlyView.
Sustainability assessment requires methodologies that appropriately distinguish between additive and non‐additive material properties. A toxicity‐weighted scoring system is developed and applied that accounts for the disproportionate influence of highly toxic constituents through nonlinear weighting functions, providing more realistic estimates than ...
Seth Mehalic, Oladele A. Ogunseitan, Julie M. Schoenung   +2 more
wiley   +1 more source

Large Language Models for World Health Organization-Uppsala Monitoring Centre Drug-Adverse Event Causality Assessment Using Food and Drug Administration Adverse Event Reporting System Cases: Comparative Performance Study. [PDF]

J Med Internet Res
Ha YM, Kim M, Bang Y, Choi D, Kim JH, Rhie SJ, Noguchi Y, Kim MG.   +7 more
europepmc   +1 more source

Printed Integrated Logic Circuits Based on Chitosan‐Gated Organic Transistors for Future Edible Systems

Advanced Functional Materials, EarlyView.
Edible electronics needs integrated logic circuits for computation and control. This work presents a potentially edible printed chitosan‐gated transistor with a design optimized for integration in circuits. Its implementation in integrated logic gates and circuits operating at low voltage (0.7 V) is demonstrated, as well as the compatibility with an ...
Giulia Coco, Valerio Francesco Annese, Valerio Galli, Ilaria Penna, Debora Russo, Marina Veronesi, Rita Scarpelli, Stefania Sabella, Mario Caironi   +8 more
wiley   +1 more source

Safety and adverse event profiles in neuromodulation therapies for drug-resistant epilepsy. [PDF]

Neurotherapeutics
Tanoue Y, Izumi M, Ahn SS, Eliashiv DS, Engel J, Bari AA, Fried I, Fallah A, Nariai H.   +8 more
europepmc   +1 more source

Pediatric spontaneous-reporting patterns for biologics approved or used for asthma: Analysis of the FDA adverse event reporting system. [PDF]

Pediatr Allergy Immunol
Zhang Y, Liu Y, Chen L, Chen Y, Zheng X.
europepmc   +1 more source

Adverse event of ACE inhibitors: A descriptive analysis of FAERS data. [PDF]

J Public Health Res
Ahmed NJ.
europepmc   +1 more source

Failure modes of robotic-assisted arthroplasty platforms in Australia: a descriptive analysis of TGA adverse event reports. [PDF]

J Robot Surg
Rowe D, Rowe M.
europepmc   +1 more source

Serious and Non-serious Hepatitis Reports in the U.S. Vaccine Adverse Event Reporting System, 1990-2026: A Cross-Sectional Analysis. [PDF]

Cureus
Aragón Gutierrez P, Botlaguduru D, Chowdary Medarametla A, Killy SP.   +3 more
europepmc   +1 more source